Earth Science Tech, Inc. filed a Form 10-Q with the SEC on November 9, 2026, covering the quarterly period ended September 30, 2026, reporting consolidated financial results for both the three and six months ended on that date.
Financial Institutions, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting third-quarter net income of $19.991 million and total assets of $6.507 billion.
Natural Gas Services Group, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting results for both the third quarter and first nine months of its fiscal year.
Forward Air Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting a third-quarter net income attributable to the company of $11.379 million and a nine-month net loss attributable to …
loanDepot, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting consolidated total assets of $6,163,751 thousand and a retained deficit of $675,879 thousand.
Natural Gas Services Group, Inc. filed a Form 8-K on November 9, 2026, announcing a cash dividend declaration by its Board of Directors and the release of its operating results for the three months ended September 30, 2026.
David J. Wilson, President and CEO of Columbus McKinnon Corp, filed a Form 4 on November 9, 2026, disclosing five open-market purchases of Columbus McKinnon common stock executed on November 5, 2026, across direct and indirect ownership accounts.
Stephen G. Oswald, an officer and director of Ducommun Inc /DE/, filed a Form 144 notice of proposed sale of 2,000 shares of common stock, with an approximate sale date of November 9, 2026, through Charles Schwab Corp.
Amgen (NASDAQ:AMGN) disclosed new clinical and health economic data for Repatha (evolocumab) at the American Heart Association Scientific Sessions 2026 on November 9, 2026, covering cost-effectiveness analyses from the VESALIUS-CV trial and long-term cardiovascular outcomes from the FOURIER open-label extension study.
Hudson Bay Capital Management LP and Sander Gerber filed a Schedule 13G with the SEC on November 9, 2026, reporting beneficial ownership of Class A Ordinary Shares of Jones Ventures INTL Acquisition1 Corp as of September 30, 2026.